Universe Pharmaceuticals (UPC) Shares Outstanding (Diluted Average) (2020 - 2022)
Universe Pharmaceuticals' (UPC) quarterly Shares Outstanding (Diluted Average) came in at $6042.0 in Q3 2022, down 99.81% year-on-year from $3.2 million in Q3 2021, and down 99.81% quarter-over-quarter from $3.2 million in Q3 2021.
Universe Pharmaceuticals (UPC) Shares Outstanding (Diluted Average) (2020 - 2022) Analysis & Trends
Universe Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $6042.0 for Q3 2022.
- Shares Outstanding (Diluted Average) for Q3 2022 came in at $6042.0, down 99.81% year-over-year; the trailing twelve-month figure through Sep 2022 was $6042.0 (down 99.81% YoY), and the FY2022 annual result was $6042.0, up 763.14% from the prior year.
- Shares Outstanding (Diluted Average) came in at $6042.0 for Q3 2022 at Universe Pharmaceuticals, down from $3.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $16.0 million in Q3 2020 to a low of $6042.0 in Q3 2022.
- The 3-year median for Shares Outstanding (Diluted Average) is $3.2 million (2021), against an average of $6.4 million.
- Across the five-year window, Shares Outstanding (Diluted Average) plunged 80.23% in 2021 and slumped 99.81% in 2022, its largest moves.
- Universe Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $16.0 million in 2020, then slumped by 80.23% to $3.2 million in 2021, then plunged by 99.81% to $6042.0 in 2022.
- The last three Shares Outstanding (Diluted Average) figures came in at $6042.0 (Q3 2022), $3.2 million (Q3 2021), and $16.0 million (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Universe Pharmaceuticals | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 6,042.00 |
| Sep 30, 2021 | 3.16 Mn |
| Sep 30, 2020 | 16.00 Mn |